뼈 및 관절 보충제 시장(2026-2030년)

The global bone and joint supplement market is forecasted to grow by USD 8368.1 mn during 2025-2030, accelerating at a CAGR of 8.6% during the forecast period. The report on the global bone and joint supplement market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating prevalence of degenerative bone disorders, surging adoption of preventive healthcare strategies among generation z, technological advancements in ingredient formulation .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global bone and joint supplement market is segmented as below:

By Product

• Vitamins and minerals
• Glucosamine and chondroitin
• Collagen supplements
• Omega 3 fatty acids
• Others

By Formulation

• Tablets
• Capsules and softgels
• Powders
• Gummies and chewable
• Liquids

By Distribution Channel

• Offline
• Online

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rise of plant-based and vegan nutritional formulations as one of the prime reasons driving the global bone and joint supplement market growth during the next few years. Also, integration of personalized nutrition and biomarker analysis and surge in demand for clean label transparency and verification will lead to sizable demand in the market.

The report on the global bone and joint supplement market covers the following areas:

• Global bone and joint supplement market sizing
• Global bone and joint supplement market forecast
• Global bone and joint supplement market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global bone and joint supplement market vendors that include Abbott Laboratories, Amway Corp., Bayer AG, Blackmores Ltd., Gaia Herbs Inc., Haleon Plc, Herbalife International Inc., Jarrow Formulas Inc., Life Extension, Natures Way Brands LLC, Nordic Naturals Inc., NOW Health Group Inc., Nutramax Laboratories Inc., Otsuka Holdings Co. Ltd., Procter and Gamble Co., Reckitt Benckiser Group Plc, Sanofi SA, Swisse, Thorne HealthTech Inc., Vitafusion. Also, the global bone and joint supplement market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Formulation
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Bone And Joint Supplement Market 2020 - 2024
  • Historic Market Size - Data Table on Global Bone And Joint Supplement Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Formulation segment analysis 2020 - 2024
  • Historic Market Size - Formulation Segment 2020 - 2024 ($ million)
• 5.4 Distribution Channel segment analysis 2020 - 2024
  • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Bone and Joint Supplement Market
• 6.2 Impact of Geopolitical Conflicts on Global Bone and Joint Supplement Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Vitamins and minerals - Market size and forecast 2025-2030
• 8.4 Glucosamine and chondroitin - Market size and forecast 2025-2030
• 8.5 Collagen supplements - Market size and forecast 2025-2030
• 8.6 Omega 3 fatty acids - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Formulation

• 9.1 Market segments
• 9.2 Comparison by Formulation
• 9.3 Tablets - Market size and forecast 2025-2030
• 9.4 Capsules and softgels - Market size and forecast 2025-2030
• 9.5 Powders - Market size and forecast 2025-2030
• 9.6 Gummies and chewable - Market size and forecast 2025-2030
• 9.7 Liquids - Market size and forecast 2025-2030
• 9.8 Market opportunity by Formulation
  • Market opportunity by Formulation ($ million)

10 Market Segmentation by Distribution Channel

• 10.1 Market segments
• 10.2 Comparison by Distribution Channel
• 10.3 Offline - Market size and forecast 2025-2030
• 10.4 Online - Market size and forecast 2025-2030
• 10.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 The Netherlands - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
  • 12.4.7 Russia - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.5.7 Singapore - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Australia - Market size and forecast 2025-2030
  • 12.6.2 Brazil - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Escalating prevalence of degenerative bone disorders
  • Surging adoption of preventive healthcare strategies among generation Z
  • Technological advancements in ingredient formulation
• 13.2 Market challenges
  • Complex matrix of stringent regulatory frameworks and compliance burdens
  • Escalating costs of premium raw materials and supply chain volatility
  • Intense market saturation and proliferation of counterfeit products
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Rise of plant-based and vegan nutritional formulations
  • Integration of personalized nutrition and biomarker analysis
  • Surge in demand for clean label transparency and verification

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Amway Corp.
  • Amway Corp. - Overview
  • Amway Corp. - Product / Service
  • Amway Corp. - Key offerings
  • SWOT
• 15.6 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
• 15.7 Haleon Plc
  • Haleon Plc - Overview
  • Haleon Plc - Business segments
  • Haleon Plc - Key offerings
  • Haleon Plc - Segment focus
  • SWOT
• 15.8 Herbalife International Inc.
  • Herbalife International Inc. - Overview
  • Herbalife International Inc. - Product / Service
  • Herbalife International Inc. - Key news
  • Herbalife International Inc. - Key offerings
  • SWOT
• 15.9 Jarrow Formulas Inc.
  • Jarrow Formulas Inc. - Overview
  • Jarrow Formulas Inc. - Product / Service
  • Jarrow Formulas Inc. - Key offerings
  • SWOT
• 15.10 Life Extension
  • Life Extension - Overview
  • Life Extension - Product / Service
  • Life Extension - Key offerings
  • SWOT
• 15.11 Nordic Naturals Inc.
  • Nordic Naturals Inc. - Overview
  • Nordic Naturals Inc. - Product / Service
  • Nordic Naturals Inc. - Key offerings
  • SWOT
• 15.12 NOW Health Group Inc.
  • NOW Health Group Inc. - Overview
  • NOW Health Group Inc. - Product / Service
  • NOW Health Group Inc. - Key offerings
  • SWOT
• 15.13 Nutramax Laboratories Inc.
  • Nutramax Laboratories Inc. - Overview
  • Nutramax Laboratories Inc. - Product / Service
  • Nutramax Laboratories Inc. - Key offerings
  • SWOT
• 15.14 Procter and Gamble Co.
  • Procter and Gamble Co. - Overview
  • Procter and Gamble Co. - Business segments
  • Procter and Gamble Co. - Key offerings
  • Procter and Gamble Co. - Segment focus
  • SWOT
• 15.15 Reckitt Benckiser Group Plc
  • Reckitt Benckiser Group Plc - Overview
  • Reckitt Benckiser Group Plc - Business segments
  • Reckitt Benckiser Group Plc - Key news
  • Reckitt Benckiser Group Plc - Key offerings
  • Reckitt Benckiser Group Plc - Segment focus
  • SWOT
• 15.16 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 15.17 Thorne HealthTech Inc.
  • Thorne HealthTech Inc. - Overview
  • Thorne HealthTech Inc. - Product / Service
  • Thorne HealthTech Inc. - Key offerings
  • SWOT
• 15.18 Vitafusion
  • Vitafusion - Overview
  • Vitafusion - Product / Service
  • Vitafusion - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations